Navigation Links
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Sector Focus Conference
Date:11/9/2007

ROCKVILLE, Md., Nov. 9 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that its presentation at the JMP Securities Sector Focus Conference will be webcast and may be accessed at http://www.hgsi.com

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

A member of Human Genome Sciences' senior management team will present an overview of the company on Tuesday, November 13, 2007 at 4:30 pm Eastern Time.

Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company's web site at http://www.hgsi.com.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Embryonic Stem Cells Repair Human Heart
2. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
3. Human Papilloma Virus vaccines may decrease chances of oral cancer
4. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
5. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
6. Toddler Study Proves Humans Outsmart Apes
7. Human C-reactive protein regulates myeloma tumor cell growth and survival
8. Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. New class of RNA molecules may be important in human cancer
11. The Humana Foundation and Libraries for the Future Launch Health Literacy Pilot in Atlanta

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...tudy finds gene variation believed to affect circa...ealthDay News) -- New research suggests that an in...a factor in the development of bipolar disorder in...ination of the genetic makeup of 152 children with...le to major mood swings, and 140 children without ...
(Date:11/27/2009)... Biotech firm Replikins Lt... the H1N1 virus genomic data. It shows that the l... 3.7 (s.d. 4.5) during the virus,s current outbrea...vels this week of 2.0 (s.d. 0.1). The H1N1 infecti... Boston (PRWEB) November 27, 2009 ...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /P...erican professional cycling team dedicated to ethi... cycling champions, announced today that it will b... Transitions Optical as a new sponsor of the team....cturer of adaptive eyewear, offering the most adva...
(Date:11/27/2009)...oaring rates to bring unprecedented medical, econo...Nov. 27 (HealthDay News) -- The number of people w...ouble over the next 25 years, a new study predicts... 44.1 million people with the disease, up from 23....of treating people with diabetes will triple, the ...
(Date:11/27/2009)... Specialist manufacturers ...roducts are saving millions of dollars by bringing... process. Increasing numbers of pro-active medical...perts at the concept stage of their projects, ensu...ting design processes or potentially outdated tech...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...archers at the Harvard Medical School it is said t... chronically infected cystic fibrosis (CF) patient...which secretes proteins that cause disease in the ...ay be a cancer patient with a weakened immune syst...
...on placed new restrictions on a doctors’ role i...st any policy //that gives medical professionals ...to use harsher tactics than they would in the abs...roups and medical ethicists. They charge that doct...
...ar excuse "not tonight, I have a headache," a new ...xual activity and says that sexual desire and migr... // In fact, migraine sufferers reported hig...eagues. 'Migraine patients in general may exp...
...lthcare products Regulatory Agency (MHRA) warned t...eadings. The diabetic patients are cautioned about...d to giving readings which were far too high. Diab...nsulin resulting in hypoglycaemic coma. It is...
...in San Diego, California, Allerca, Inc., is now t...kitten, the world’s first hypoallergenic cats //.T...o are also cat lovers. Allerca sources claim ...ng. Hence these animals were not transgenic,in oth...
...s at the Johns Hopkins Bloomberg School of Public ...lar immune tactics to ward off bacterial// pathoge...wn on the different genes connected with the prote...rtant for the resistance to bacterial infection. H...
Other Medicine News:Health News:Treatment of Bacterial Infection Paves the Way to Treat CF Infection 2Health News:Medical Role In Interrogations Curtailed By Pentagon 2Health News:What Ticks the Mosquito immune system? 2
(Date:11/25/2009)... , WALTHAM, Mass., Nov. 25 Acc...bal authority on medical technology market intelli...fixation devices will continue to see rapid growth...mic slowdown. MRG,s US Markets for Trauma Devices... highly dynamic over the next five years, with com...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlin...t is available in its catalogue: ,, Intranasal... http://www.reportlinker.com/p0164267/Intranasal-D..., The US intranasal drug delivery market is witn...om the delivery of conventional local therapeutic ...
(Date:11/24/2009)... , BETHESDA, Md., Nov. 24 /PRNewswire-Asia/...q: CHDX ), a leading independent American provide...he People,s Republic of China, today,announced tha...ffray,"Unplugged" Health Care Conference, to be he...tel. , Management is currently scheduled ...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Indiana Drug Card to Provide Free Drug Cards to Residents 53014 1Indiana Drug Card to Provide Free Drug Cards to Residents 53014 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 1Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 3Tanning Beds Get Highest Carcinogen Rating 53009 1Tanning Beds Get Highest Carcinogen Rating 53009 2Tanning Beds Get Highest Carcinogen Rating 53009 3
...ath by 13% (P=0.08), despite inclusion of patients... , - In a separate censored analysis excluding...tion in risk of death was 19% , , - Long-term...einforces starting with Femara as the optimal trea...VER, N.J., Dec. 11 New long-term data from a majo...
...Jersey and PHILADELPHIA, December 11, Rosetta Geno...icroRNA-based molecular diagnostics, announced tod...stic test, miRview(TM) squamous.,The test is now c...A-certified lab in Philadelphia. , To order ...r visit the,company,s website http://www.rosettag...
Other Medicine Technology:Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 2Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 3Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 4Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 5Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 6Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 7Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 8Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 2Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 3Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 4Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 5
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: